Lab to Lives

Sophia Zilber: Getting to quality research from patient registries

Sam Parnell & Ivanna Rosendal Season 3 Episode 3

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 34:35

Send us Fan Mail

 Today is World Rare Disease day. It is only fitting that we speak to Sophia Zilber who is a statistical programmer, but also Board Member & Director of Patient Registries at the Cure MITO Foundation, about bridging the gap between the life sciences industry and patient registries in rare diseases

Sophia has experienced first hand how rare diseases lack both data and funding. Using her personal tragedy and statistical programming skills, Sophia engaged in patient advocacy groups attempting to collect patient data for research.  

Pharmaceutical companies are often looking for data sources to understand diseases. And patient advocacy groups are eagerly collecting data in the hopes that it will make a difference for finding treatment and cures. But in many cases the data collected is not usable for actual research purposes. 

Currently there is no guidance on how to create a patient registry that will contain a high enough quality of data to be used for research. Sophia is actively working to change that through multiple efforts, such as a Phuse working group  - and shares with us her advice for how to ensure data quality. 


Guest:

Sophia Zilber

https://www.linkedin.com/in/sophiazilber/
https://sophiazilber.carrd.co/


Cure MITO Foundation

https://www.linkedin.com/company/cure-mito-foundation/ 


Phuse:

https://www.linkedin.com/company/phuse/ 

Visit Labtolives.com

Do you want to try the quiz from this episode? Find the link on our LinkedIn profile: https://www.linkedin.com/company/labtolives/ 

Would you like to join the show as a guest or collaborator? Find out how on our website: https://www.labtolives.com/ 


Support the show


________
Reach out to Ivanna Rosendal

Join the conversation on our LinkedIn page


Hosts

Alexander Booth aka the MedTech Guy

Dimitri Borisevich aka the start-up Guy

Ivanna Rosendal aka the R&D pharma Gal